Amedisys Floats Future Innovation Plans, Details COVID-19 Costs
About five months into the COVID-19 crisis, Amedisys Inc. (Nasdaq: AMED) believes that it’s better positioned for the future than it was before COVID-19 landed on U.S. soil. The Patient-Driven Groupings Model (PDGM) and COVID-19 have presented challenges to the Baton Rouge, Louisiana-based company’s home… Read More »Amedisys Floats Future Innovation Plans, Details COVID-19 Costs
